BloombergLean L·
Sellas Life Sciences Stock Triples After Cancer Vaccine Data
Sellas Life Sciences Group Inc. surged after the drug developer reported positive late-stage trial results for an experimental cancer vaccine to treat an aggressive form of blood cancer.
Read at Bloomberg →